Cargando…

360 Waste not, test more: Innovations in tissue processing to expand the testing of clinical specimens

OBJECTIVES/GOALS: Clinical tissue specimens are primarily destined for formalin fixed, paraffin embedded processing to create a basis for diagnosis by microscopic examination. Innovations in specimen processing are required to expand its availability for inclusion as the substrate in assays that can...

Descripción completa

Detalles Bibliográficos
Autores principales: Mojica, Wilfrido, Yang, Bei, Hsu, Chang Chieh, Wu, Yun, Izydorczak, Alexandra, Wood, Troy D., Cho, Dara, Parashurama, Natesh, Yergeau, Donald, Mahajan, Supriya D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129836/
http://dx.doi.org/10.1017/cts.2023.400
_version_ 1785030842409549824
author Mojica, Wilfrido
Yang, Bei
Hsu, Chang Chieh
Wu, Yun
Izydorczak, Alexandra
Wood, Troy D.
Cho, Dara
Parashurama, Natesh
Yergeau, Donald
Mahajan, Supriya D
author_facet Mojica, Wilfrido
Yang, Bei
Hsu, Chang Chieh
Wu, Yun
Izydorczak, Alexandra
Wood, Troy D.
Cho, Dara
Parashurama, Natesh
Yergeau, Donald
Mahajan, Supriya D
author_sort Mojica, Wilfrido
collection PubMed
description OBJECTIVES/GOALS: Clinical tissue specimens are primarily destined for formalin fixed, paraffin embedded processing to create a basis for diagnosis by microscopic examination. Innovations in specimen processing are required to expand its availability for inclusion as the substrate in assays that can contribute to the further development of Precision Medicine. METHODS/STUDY POPULATION: Transurethral resection of bladder tumors were selected for testing based on availability and tissue composition. A wash step was used to generate daughter aliquots composed of dislodged cells and a solution with prior contact to the parent tissue. This wash step served two purposes: 1) reduce the amount of contaminating material from spreading to other cases, a problem known to be associated with this type of specimen; and 2) create aliquots from which additional informative data could be generated. These daughter aliquots were then examined to determine their value as a source for exosome profiling, metabolomic studies, molecular characterization and organoid development. The parent tissue was not compromised, was able to undergo conventional processing and yielded results equivalent to unwashed specimens. RESULTS/ANTICIPATED RESULTS: Exosomes secreted by the tumor cells were identified to be present in the daughter aliquots by a combination of their isolation using CD31 and detection of miR-21 expression. These exosomes were confirmed to be not related to fragmented cells from testing for beta-tubulin. A global/discovery-based approach using mass spectrometry provided insights into early characterization of metabolomic profiles present in these tumor cells. Ample amounts of high quality DNA (226 ng/ul concentrations; 11.3 ug total) were recovered from the dislodged, excess cells in the wash for molecular studies. Finally, from viable cells recovered in one of the daughter wash aliquots, the ability to grow organoids was proven to be possible and reproducible. DISCUSSION/SIGNIFICANCE: Based on these results, the value of the clinical specimen can be markedly expanded for utilization in research and possible clinical use without detracting from the parent tissue. This non-destructive, easy to adopt wash procedure can potentially lead to an influx of data that may ultimately prove useful in improving patient care.
format Online
Article
Text
id pubmed-10129836
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-101298362023-04-26 360 Waste not, test more: Innovations in tissue processing to expand the testing of clinical specimens Mojica, Wilfrido Yang, Bei Hsu, Chang Chieh Wu, Yun Izydorczak, Alexandra Wood, Troy D. Cho, Dara Parashurama, Natesh Yergeau, Donald Mahajan, Supriya D J Clin Transl Sci Precision Medicine/Health OBJECTIVES/GOALS: Clinical tissue specimens are primarily destined for formalin fixed, paraffin embedded processing to create a basis for diagnosis by microscopic examination. Innovations in specimen processing are required to expand its availability for inclusion as the substrate in assays that can contribute to the further development of Precision Medicine. METHODS/STUDY POPULATION: Transurethral resection of bladder tumors were selected for testing based on availability and tissue composition. A wash step was used to generate daughter aliquots composed of dislodged cells and a solution with prior contact to the parent tissue. This wash step served two purposes: 1) reduce the amount of contaminating material from spreading to other cases, a problem known to be associated with this type of specimen; and 2) create aliquots from which additional informative data could be generated. These daughter aliquots were then examined to determine their value as a source for exosome profiling, metabolomic studies, molecular characterization and organoid development. The parent tissue was not compromised, was able to undergo conventional processing and yielded results equivalent to unwashed specimens. RESULTS/ANTICIPATED RESULTS: Exosomes secreted by the tumor cells were identified to be present in the daughter aliquots by a combination of their isolation using CD31 and detection of miR-21 expression. These exosomes were confirmed to be not related to fragmented cells from testing for beta-tubulin. A global/discovery-based approach using mass spectrometry provided insights into early characterization of metabolomic profiles present in these tumor cells. Ample amounts of high quality DNA (226 ng/ul concentrations; 11.3 ug total) were recovered from the dislodged, excess cells in the wash for molecular studies. Finally, from viable cells recovered in one of the daughter wash aliquots, the ability to grow organoids was proven to be possible and reproducible. DISCUSSION/SIGNIFICANCE: Based on these results, the value of the clinical specimen can be markedly expanded for utilization in research and possible clinical use without detracting from the parent tissue. This non-destructive, easy to adopt wash procedure can potentially lead to an influx of data that may ultimately prove useful in improving patient care. Cambridge University Press 2023-04-24 /pmc/articles/PMC10129836/ http://dx.doi.org/10.1017/cts.2023.400 Text en © The Association for Clinical and Translational Science 2023 https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
spellingShingle Precision Medicine/Health
Mojica, Wilfrido
Yang, Bei
Hsu, Chang Chieh
Wu, Yun
Izydorczak, Alexandra
Wood, Troy D.
Cho, Dara
Parashurama, Natesh
Yergeau, Donald
Mahajan, Supriya D
360 Waste not, test more: Innovations in tissue processing to expand the testing of clinical specimens
title 360 Waste not, test more: Innovations in tissue processing to expand the testing of clinical specimens
title_full 360 Waste not, test more: Innovations in tissue processing to expand the testing of clinical specimens
title_fullStr 360 Waste not, test more: Innovations in tissue processing to expand the testing of clinical specimens
title_full_unstemmed 360 Waste not, test more: Innovations in tissue processing to expand the testing of clinical specimens
title_short 360 Waste not, test more: Innovations in tissue processing to expand the testing of clinical specimens
title_sort 360 waste not, test more: innovations in tissue processing to expand the testing of clinical specimens
topic Precision Medicine/Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129836/
http://dx.doi.org/10.1017/cts.2023.400
work_keys_str_mv AT mojicawilfrido 360wastenottestmoreinnovationsintissueprocessingtoexpandthetestingofclinicalspecimens
AT yangbei 360wastenottestmoreinnovationsintissueprocessingtoexpandthetestingofclinicalspecimens
AT hsuchangchieh 360wastenottestmoreinnovationsintissueprocessingtoexpandthetestingofclinicalspecimens
AT wuyun 360wastenottestmoreinnovationsintissueprocessingtoexpandthetestingofclinicalspecimens
AT izydorczakalexandra 360wastenottestmoreinnovationsintissueprocessingtoexpandthetestingofclinicalspecimens
AT woodtroyd 360wastenottestmoreinnovationsintissueprocessingtoexpandthetestingofclinicalspecimens
AT chodara 360wastenottestmoreinnovationsintissueprocessingtoexpandthetestingofclinicalspecimens
AT parashuramanatesh 360wastenottestmoreinnovationsintissueprocessingtoexpandthetestingofclinicalspecimens
AT yergeaudonald 360wastenottestmoreinnovationsintissueprocessingtoexpandthetestingofclinicalspecimens
AT mahajansupriyad 360wastenottestmoreinnovationsintissueprocessingtoexpandthetestingofclinicalspecimens